Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis

Journal of Pharmaceutical Sciences

Volumn 86, Issue 12, 1997, Pages 1497-1500

  Ramaiya, Atulkumar ^a   Johnson, James H ^a   Thomas Karnes, H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MINIMUM INHIBITORY CONCENTRATION; NEUROPHARMACOLOGY; NONHUMAN; RAT; SEROTONIN RELEASE;

EID: 0031461069     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970253z     Document Type: Article

References (21)

1. Haddock, R. E.; Johnson, A. M; Langley, P. F.; Nelson, D. R.; Pope, J. A.; Thomas, D. R.; Woods, F. R. Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites. Acta Psychiatr. Scan. 1989, 80 (suppl. 350), 24-26.
2. Lassen, J. B. Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. Eur. J. Pharmacol. 1978, 47, 351358.
3. Thomas, D. R.; Nelson, D. R.; Johnson, A. M. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 1987, 193-200.
4. Magnussen, L; Tpender, K.; Engbaek, F. Paroxetine, a potent selective long-acting inhibitor of synaptosomal 5-HT uptake in mice. J. Neural Transmission 1982, 55, 217.
5. Johnson, A. M.; Nelson, D. R.; Thomas, D. R. Effect of paroxetine and other 5-Hydroxytryptamine uptake inhibitors on central monoamine uptake in vitro and ex vivo. Br. J. Pharmacol. 1985, 85, 221.
6. Wong, S. L.; Wang, Y.; Sawchuk, R. J. Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis. Pharm. Res. 1992, 9, 332-338.
7. Westerink, B. H. C.; Justice, J. B., Jr. Microdialysis compared with other in vivo release models. In Microdialysis in the Neurosciences; Robinson, T. E.; Justice, J. B., Jr., Eds.; Elsevier: Amsterdam, 199; p 23.
8. Tulloch, I. F.; Johnson, A. M. The pharmacologie profile of paroxetine, a new selective serotonin reuptake inhibitor. J. Clin. Psychiatr. 1992, 53 (Suppl. 2), 7-12.
9. Fuller, R. W. Basic advances in serotonin pharmacology. J. Clin. Psychiatr. 1992, 53 (suppl. 10), 36-45.
10. Perry, K. W.; Fuller, R. W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sei. 1992, 50, 1683-1690.
11. Kaien, P.; Strecker, R. E.; Rosengren, E.; Björklund, A. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J. Neurochem. 1988, 51, 1422-1435.
12. deGroot, J. The rat brain in stereotaxic coordinates. Verh. K. ned. Akad. Wet, Natuurkund. 1959, 52, I.
13. Ramaiya, A.; Karnes, H. T. Simultaneous measurement of serotonin and paroxetine in rat brain microdialysate by single pump column switching technique. J. Chromatogr. B. 1997, 691, 119-129.
14. SAS/Stat User's Guide, Version 6, Fourth Edition, Volume 2; SAS Institute Inc.: Cary, NC, 1989.
15. Fuller, R. W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sei. 1994, 55, 163-167.
16. Fuller, R. W.; Wong, D. T.; Fluoxetine: A serotonergic appetite suppressant drug. Drug. Dev. Res. 1989, 77, 1.
17. Fuller, R. W.; Wong, D. T. Serotonin uptake and serotonin uptake inhibition. Ann N. Y. Acad. Sei. 1990, 600, 68-78.
18. Auerbach, S.; Minzenberg, M. J.; Wilkinson, L. O. Extracellular serotonin and hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to highperformance liquid chromatography with electrochemical detection, dialysate serotonin reflects neuronal release. Brain Res. 1989, 499, 281-290.
19. Knott, P. J. Modern methods for studying the release of serotonin. In Neuronal Serotonin; Osborne, N. N.; Hamon, M., Eds.; John Wiley & Sons: New York, 1988; p 93.
20. Caccia, S.; Anelli. M.; Codegoni, A. M.; Fracasse, C.; Garattini, S. The effects of single and repeated anorectic doses of 5-hydroxyryptamine uptake inhibitors on the indole levels in rat brain. Br. J. Pharmacol. 1993, 110, 355-359.
21. Kaye, C. M.; Haddock, R. E.; Langley, P. F.; Mellows, G.; Tacker, T. C. G.; Zussman, B. D.; Greb, W. H. A review of the metabolism and pharmacokinetics of paroxetine in man. Acta, Psychiatr. Scan. 1989, 80 (suppl. 350), 60-75.